» Articles » PMID: 11015369

Rapid Differentiation of Fermentative from Nonfermentative Gram-negative Bacilli in Positive Blood Cultures by an Impedance Method

Overview
Specialty Microbiology
Date 2000 Oct 4
PMID 11015369
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Rapid differentiation of fermentative gram-negative bacilli (fermenters) from nonfermentative gram-negative bacilli (nonfermenters) in positive blood cultures may help physicians to narrow the choice of appropriate antibiotics for empiric treatment. An impedance method for direct differentiation of fermenters from nonfermenters was investigated. The bacterial suspensions (or positive culture broths containing gram-negative bacteria) were inoculated into the module wells of a Bactometer (bioMérieux, Inc., Hazelwood, Mo.) containing 1 ml of Muller-Hinton broth. The inoculated modules were incubated at 35 degrees C, and the change in impedance in each well was continuously monitored. The amount of time required to cause a series of significant deviations from baseline impedance values was defined as the detection time (DT). The percent change of impedance was defined as the change of impedance at the time interval from DT to DT plus 1 h. After testing 857 strains of pure cultures (586 strains of fermenters and 271 strains of nonfermenters), a breakpoint (2.98%) of impedance change was obtained by discriminant analysis. Strains displaying impedance changes of greater than 2.98% were classified as fermenters; the others were classified as nonfermenters. By using this breakpoint, 98.6% (340 of 345) of positive blood cultures containing fermenters and 98% (98 of 100) of positive blood cultures containing nonfermenters were correctly classified. The impedance method was simple, and the results were normally available within 2 to 4 h after direct inoculation of positive blood culture broths.

Citing Articles

The Role of Automation for Early Diagnosis of Non-fermenter Superbugs in Critically Ill Septicemic Hospitalized Patients.

Agarwal K, Agrawal S, Begum N, Jindal S Cureus. 2023; 15(7):e41484.

PMID: 37551224 PMC: 10404334. DOI: 10.7759/cureus.41484.


as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.

Adegoke A, Stenstrom T, Okoh A Front Microbiol. 2017; 8:2276.

PMID: 29250041 PMC: 5714879. DOI: 10.3389/fmicb.2017.02276.


Rapid clinical bacteriology and its future impact.

van Belkum A, Durand G, Peyret M, Chatellier S, Zambardi G, Schrenzel J Ann Lab Med. 2013; 33(1):14-27.

PMID: 23301218 PMC: 3535192. DOI: 10.3343/alm.2013.33.1.14.

References
1.
Daschner F, Langmaack H, Grehn M, Steffens A, Just M . Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria. Chemotherapy. 1981; 27(1):39-43. DOI: 10.1159/000237953. View

2.
Edgeworth J, Treacher D, Eykyn S . A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med. 1999; 27(8):1421-8. DOI: 10.1097/00003246-199908000-00002. View

3.
Just H, Beckert A, Bassler M, Daschner F . Combination effect of ceftriaxone with four aminoglycosides on nonfermenting gram-negative bacteria. Chemotherapy. 1982; 28(5):397-401. DOI: 10.1159/000238128. View

4.
Appelbaum P, Tamim J, Pankuch G, Aber R . Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam. Chemotherapy. 1983; 29(5):337-44. DOI: 10.1159/000238217. View

5.
Appelbaum P, Spangler S, Tamarree T . Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin. Chemotherapy. 1988; 34(1):40-5. DOI: 10.1159/000238546. View